2月9日，慧辰股份涨5.05%，截至发稿，报61.79元/股，成交8644.56万元，换手率1.95%，总市值46.53 亿元。 中信建投智信物联网A（001809）成立日期2016年8月3日，最新规模1.18亿。今年以来收益12.77%，同 类排名373/8994；近一年收益8.81%，同类排名6481/8194；成立以来收益34.43%。 资料显示，北京慧辰资道资讯股份有限公司位于北京市朝阳区酒仙桥北路甲10号院102号楼6层，成立日 期2008年11月14日，上市日期2020年7月16日，公司主营业务涉及为行业头部企业和国内政府机构提供 基于企业内外部数据、消费者态度与行为数据和行业数据的业务经营分析与应用、定制化行业分析应用 解决方案等服务。主营业务收入构成为：数据产品83.82%，解决方案16.18%。 从基金十大重仓股角度 数据显示，中信建投基金旗下1只基金重仓慧辰股份。中信建投智信物联网A（001809）四季度持有股 数16.3万股，占基金净值比例为4.94%，位居第二大重仓股。根据测算，今日浮盈赚取约48.4万元。 中信建投智信物联网A（001809）基金经理为周紫光。 截至发稿，周紫光累计任 ...

Core Insights - The distinction between "pure body" and "body + large model" factions in humanoid robotics is becoming increasingly blurred, indicating a shift in industry focus towards intelligent interaction rather than just hardware capabilities [1][2][4] Group 1: Industry Trends - Industry leaders are recognizing the importance of integrating advanced models into humanoid robotics, with a notable shift in narrative as traditional "body" manufacturers begin to emphasize the significance of "brains" [2][5] - The competition is evolving from merely enhancing production capacity to a new battleground focused on intelligent interaction and model development [4][10] Group 2: Strategic Collaborations - Several body manufacturers are actively pursuing partnerships to enhance their model capabilities, such as the strategic collaborations between Songyan Power and Huichen, and Zhongqing Robotics with Fengwu Technology [6][8] - The launch of various models by companies like Yushu Technology and Ant Group reflects a rapid development in the foundational technology for embodied intelligence [8][9] Group 3: Market Dynamics - The humanoid robotics market is maturing, with over 140 companies and more than 330 products released, indicating that humanoid robots are no longer rare [10][13] - The production capabilities have significantly improved, with a new platform capable of producing 5,000 units annually, highlighting the industry's transition from a challenging task to a mature industrial capability [11][13] Group 4: Opportunities and Challenges - The shift towards model integration presents both challenges and opportunities, as companies must compete with established players while also developing their own model capabilities [14][15] - The market is not closing opportunities for smaller companies, as flexibility and targeted approaches can still lead to breakthroughs in niche areas [15][16] Group 5: Valuation and Investment Landscape - The valuation of companies in the embodied intelligence sector is heavily influenced by their model capabilities, with leading firms being those that are model-driven or utilize a dual approach [16][17] - The industry's focus is shifting from mere production to a comprehensive system capability, emphasizing the need for both physical and intelligent components to succeed [19][20]

Core Insights - The integration of digital economy and physical industries has made data a core production factor for driving business decisions and market insights [1] - The importance of industry data analysis and market research is increasingly recognized as a key process for transforming raw data into strategic intelligence [1] - A reliable data analysis partner can help businesses understand market trends, consumer behavior, and competitive dynamics, thereby building sustainable competitive advantages [1] Industry Data Analysis and Research Company Recommendations - **Guangzhou Cidian Market Research Co., Ltd.**: A leading independent market research agency in China, offering customized market research solutions across various sectors, including consumer behavior insights and market entry strategy evaluations [3][4] - **Beijing Huichen Zidao Information Co., Ltd.**: A publicly listed company focused on data intelligence analysis services, combining data technology with industry knowledge to provide business insights and decision support [5] - **Shanghai Nielsen Market Research Co., Ltd.**: The Chinese branch of the global data analysis company Nielsen, known for its consumer behavior monitoring and market measurement services [6] - **Ipsos (China) Market Research Consulting Co., Ltd.**: The Chinese operation of the international market research group Ipsos, providing comprehensive market research and social research services [7] - **CCTV Market Research Co., Ltd.**: A leading provider of media and consumer market research services in China, recognized for its authority in media ratings and consumer behavior tracking [8] Company Selection Guidelines - When selecting an industry data analysis service provider, companies should consider their research goals, budget, industry characteristics, and data depth and breadth requirements [9] - Guangzhou Cidian Market Research Co., Ltd. excels in offline execution networks and customized solutions, making it suitable for projects requiring in-depth interviews and field observations [10] - Beijing Huichen Zidao Information Co., Ltd. stands out for its data technology-driven approach and productized analysis capabilities, ideal for clients seeking advanced data integration and predictive modeling [10]

上市首日，慧辰股份盘中创下最高点报121.00元，为公司上市以来最高价。 中国经济网北京1月23日讯 慧辰股份(688500.SH)昨晚披露2025年年度业绩预告。 经公司财务部门初步测算，预计公司2025年度归属于母公司所有者的净利润为-4,600万元到-3,200 万元。与上年同期相比，预计减少亏损739.72万元到2,139.72万元，亏损幅度同比收窄13.85%到 40.07%。 2025年度归属于母公司所有者扣除非经常性损益后的净利润预计为-6,300万元到-4,500万元。与上 年同期相比，预计减少亏损4,306.16万元到6,106.16万元，亏损幅度同比收窄40.60%到57.57%。 慧辰股份于2020年7月16日在上交所科创板上市，发行数量为1,856.8628万股，全部为公开发行新 股，无老股转让，发行价格为34.21元/股，保荐机构（主承销商）为中信证券股份有限公司，保荐代表 人为李艳梅、马孝峰。 2020年、2021年、2022年、2023年，慧辰股份实现归属于上市公司股东的净利润分别为1648.90万 元、-2929.86万元、-8666.97万元、-1.70亿元；归属于上市公司股 ...

2025年，公司凭借在自身业务领域长期积累的竞争优势和优质的客户资源，专注于业务开拓、产品研发 和高质量交付，稳扎和深挖主营业务基本盘，但受行业竞争格局变动影响，市场竞争加剧，以及报告期 内实施股权激励产生股份支付，导致公司营业收入总规模尚未能覆盖运营成本和期间费用，未能实现盈 利。 慧辰股份(688500.SH)发布2025年年度业绩预告，预计公司2025年度归属于母公司所有者的净利润 为-4,600万元到-3,200万元。与上年同期相比，预计减少亏损739.72万元到2,139.72万元，亏损幅度同比 收窄13.85%到40.07%。 ...

智通财经APP讯，慧辰股份(688500.SH)发布2025年年度业绩预告，预计公司2025年度归属于母公司所 有者的净利润为-4,600万元到-3,200万元。与上年同期相比，预计减少亏损739.72万元到2,139.72万元， 亏损幅度同比收窄13.85%到40.07%。 2025年，公司凭借在自身业务领域长期积累的竞争优势和优质的客户资源，专注于业务开拓、产品研发 和高质量交付，稳扎和深挖主营业务基本盘，但受行业竞争格局变动影响，市场竞争加剧，以及报告期 内实施股权激励产生股份支付，导致公司营业收入总规模尚未能覆盖运营成本和期间费用，未能实现盈 利。 ...

Group 1 - Huakang Clean announced it is the first candidate for the bid of the Wuhan First Hospital expansion project with a bid amount of 54.88 million yuan and a construction period of 120 days [1] - Hualing Steel's subsidiary plans to invest 449.88 million yuan in a major overhaul project for its coking plant, aiming to address aging issues and restore production capacity over a 19-month construction period [2] - Yinjia Technology expects a net loss of 140 million to 110 million yuan for 2025, compared to a loss of 129 million yuan in the previous year [3] Group 2 - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan for 2025, recovering from a loss of 58.52 million yuan in the previous year [4] - Shiyi Da anticipates a net profit increase of 31 million to 46 million yuan for 2025, turning around from a loss of 23.41 million yuan last year [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, representing a decline of 45.05% to 60.03% compared to the previous year [7] Group 3 - Xindian Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 42 yuan per share [6] - Jingchen Co. has set the initial transfer price for its shares at 82.85 yuan per share, with a total of 13.1 million shares to be transferred to 28 institutional investors [8] - Zejing Pharmaceutical received approval for clinical trials of its innovative cancer immunotherapy drug ZG005 in combination with platinum-based chemotherapy for advanced nasopharyngeal and esophageal squamous cell carcinoma [9] Group 4 - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, marking a growth of 95.82% to 121.56% compared to the previous year [10] - Liancheng Precision anticipates a net loss of 12 million to 17 million yuan for 2025, reducing its loss from 37.96 million yuan in the previous year [11] - Beidou Star expects a net loss of 230 million to 290 million yuan for 2025, improving from a loss of 350 million yuan last year [13] Group 5 - Qing Shan Paper's affiliate won a bid for a wastewater treatment project worth 51.9 million yuan [15] - Yiling Pharmaceutical forecasts a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year [16] - Huahai Pharmaceutical received a drug registration certificate for its product used in treating depression and obsessive-compulsive disorder [23] Group 6 - Nanjing Panda expects a net profit of 10 million to 15 million yuan for 2025, turning around from a loss of 189 million yuan last year [40] - Rui Sheng Intelligent anticipates a net profit of 33.92 million to 38.40 million yuan for 2025, representing a growth of 112% to 140% compared to the previous year [41] - Jiechang Drive expects a net profit of 395 million to 437 million yuan for 2025, with a growth of 40% to 55% compared to the previous year [43]

证券代码：688500 证券简称：慧辰股份 公告编号：2026-006 北京慧辰资道资讯股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （一）营业收入：44,403.95 万元。 （二）利润总额：-4,217.74 万元。归属于母公司所有者的净利润：-5,339.72 万元。归属于母公司所有者的扣除非经常性损益的净利润：-10,606.16 万元。 （三）每股收益：-0.73 元。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 1、经北京慧辰资道资讯股份有限公司（以下简称"公司"）财务部门初步 测算，预计公司 2025 年度归属于母公司所有者的净利润为-4,600 万元到-3,200 万元。与上年同期相比，预计减少亏损 739.72 万元到 2,139.72 万元，亏损幅度 同比收窄 13.85%到 40.07%。 2、2025 年度归属于母公司所有者扣除非经常性损益后的净利润预计为 -6,300 万 ...

报告期内，公司努力解决历史遗留问题及推行组织优化，强化业务管控，继续采取加强应收账款管理、 费用管控等举措，逐步改善经营成效，经营性净现金流较上年大幅改善，本期计提信用减值、资产减值 等损失较上年大幅减少；报告期内，公司部分募投研发项目收尾结项，新技术研发项目逐步启动，使得 期间研发费用相对上年阶段性下降；公司根据中小股东诉讼赔偿案件诉讼进展及截止期末实际赔偿情 况，基于已经结案或即将结案的案件，预计冲减上年已计提的预计负债约1,160万元。受上述各因素共 同影响，公司实现了亏损同比收窄的经营绩效。 格隆汇1月22日丨慧辰股份（维权）(688500.SH)公布，公司财务部门初步测算，预计公司2025年度归属 于母公司所有者的净利润为-4,600万元到-3,200万元。与上年同期相比，预计减少亏损739.72万元到 2,139.72万元，亏损幅度同比收窄13.85%到40.07%。2025年度归属于母公司所有者扣除非经常性损益后 的净利润预计为-6,300万元到-4,500万元。与上年同期相比，预计减少亏损4,306.16万元到6,106.16万 元，亏损幅度同比收窄40.60%到57.57%。 2025年，公 ...

Core Viewpoint - The company, Huichen Co., Ltd. (688500.SH), anticipates a reduction in losses for the fiscal year 2025, with projected net losses narrowing compared to the previous year, despite ongoing challenges in the competitive landscape [1][2]. Group 1: Financial Projections - The company estimates a net loss attributable to shareholders of the parent company for 2025 to be between -46 million to -32 million yuan, representing a decrease in losses by 7.4 million to 21.4 million yuan compared to the previous year, with a year-on-year loss reduction of 13.85% to 40.07% [1]. - The projected net loss after deducting non-recurring gains and losses is expected to be between -63 million to -45 million yuan, indicating a reduction in losses by 43.1 million to 61.1 million yuan year-on-year, with a loss narrowing of 40.60% to 57.57% [1]. Group 2: Operational Improvements - The company has been addressing historical issues and implementing organizational optimizations to strengthen business management, which has led to a significant improvement in operating cash flow compared to the previous year [2]. - Efforts to manage accounts receivable and control expenses have contributed to a gradual improvement in operational performance, with substantial reductions in credit impairment and asset impairment losses compared to the previous year [2]. - The company has completed some fundraising research and development projects while gradually initiating new technology R&D projects, resulting in a temporary decrease in R&D expenses compared to the previous year [2].